Bank of America Corporation (NYSE:BAC) caters to the Financial space. It has a net profit margin of 30.30% and weekly performance is 1.57%. On the last day of trading company shares ended up at $16.78. Bank of America Corporation (NYSE:BAC) distance from 50-day simple moving average (SMA50) is 5.31%.
Bank of America Corporation (NYSE:BAC) had its target price decreased by Deutsche Bank from $20.00 to $19.00 in a research report released on Tuesday,StockTargetPrices.com reports.
Dynamic Materials Corp. (NASDAQ:BOOM) ended the last trading day at $7.13. Company weekly volatility is calculated as 7.73% and price to cash ratio as 9.28. Dynamic Materials Corp. (NASDAQ:BOOM) showed a weekly performance of -25.11%.
On 27 October, Dynamic Materials Corp. (NASDAQ:BOOM) reported financial results for its third quarter and nine-month period ended September 30, 2015. Third quarter sales were $39.5 million, down 24% from $51.9 million in the 2014 third quarter. Approximately $3.5 million of the decline was related to unfavorable foreign currency exchange translation
On 30 October, Eaton Vance Corp. (NYSE:EV) shares decreased -0.66% and was closed at $36.11. EV EPS growth in last 5 year was 17.90%. Eaton Vance Corp. (NYSE:EV) year to date (YTD) performance is -9.45%.
On 30 October, Eaton Vance Corp. (NYSE:EV) released the estimated sources of their October distributions (each a “Fund”). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission.
Brightcove Inc. (NASDAQ:BCOV) shares advanced 15.03% in last trading session and ended the day at $6.20. BCOV Gross Margin is 64.90% and its has a return on assets of -11.20%. Brightcove Inc. (NASDAQ:BCOV) quarterly performance is 10.52%.
On 29 October, Brightcove Inc. (NASDAQ:BCOV) announced financial results for the quarter ended September 30, 2015. Revenue for the third quarter of 2015 was $33.8 million, an increase of 7% compared to $31.5 million for the third quarter of 2014. Subscription and support revenue was $33.2 million, an increase of 9% compared with $30.5 million for the third quarter of 2014.
Cytokinetics, Incorporated (NASDAQ:CYTK) caters to the Healthcare space. It has a net profit margin of -40.60% and weekly performance is 25.88%. On the last day of trading company shares ended up at $8.61. Cytokinetics, Incorporated (NASDAQ:CYTK) distance from 50-day simple moving average (SMA50) is 8.19%.
On 27 October, Cytokinetics, Incorporated (NASDAQ:CYTK) announced that data from the expansion phase of COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure), a Phase 2 trial evaluating omecamtiv mecarbil in patients with chronic heart failure, showed statistically significant improvements in several measures of cardiac function, including systolic ejection time, stroke volume and N-terminal-pro-brain natriuretic peptide, at 20 weeks following randomization.
Leave a Reply